Shiitake Extract Supplier (Lentinula edodes): Polysaccharides 20–50% & 10:1/20:1 Ratio | Beta-Glucan & Lentinan B2B Guide
Fresh shiitake contains up to 90% water, leaving minimal bioactive content per gram and making the raw mushroom impractical for formulation. Dried powder improves concentration but does not break down the chitinous cell walls that lock in the mushroom’s key compounds. Standardized shiitake extract, produced through hot-water or dual-solvent extraction, addresses both: it concentrates the bioactive fraction and disrupts the cell wall so beta-glucans and lentinan become accessible. Valeherb supplies shiitake extract standardized to 20–50% polysaccharides by UV-Vis (beta-glucan-specific quantification available), as well as ratio extracts (10:1, 20:1, HPLC fingerprint available).
Active Compounds: What Drives Shiitake’s Functional Value
Lentinula edodes contains several biologically active compound classes; two are the primary focus of research on its immune and cardiovascular-related activity:[5]
| Compound | Structure / Type | Activity Studied in Research |
|---|---|---|
| Lentinan | β-1,3:β-1,6-glucan; triple-helix conformation | Studied for immunomodulation via macrophage, T-cell, and NK-cell activation. The triple-helix structure is the functional form — denaturation to single strand markedly reduces activity in research[5] |
| Beta-Glucans (total) | Mixed β-1,3 and β-1,6 polysaccharide fraction | Studied for innate-immune priming; dectin-1 receptor engagement on immune cells[2] |
| Eritadenine | Adenosine derivative; unique to shiitake | Studied for inhibition of S-adenosylhomocysteine hydrolase and effects on cholesterol metabolism in research models[3] |
| Ergosterol | Provitamin D2 precursor | Converts to vitamin D2 on UV exposure; of interest for combined immune and vitamin-D supplement formats |
Three Research-Documented Activity Areas
1. Immune Modulation
Lentinan is among the most studied of the mushroom polysaccharides. A randomized, double-blind, placebo-controlled crossover trial by Gaullier et al. (2011) reported that oral β-glucan from shiitake mycelium was associated with increased circulating B-cell counts in healthy elderly participants versus placebo.[1] In research, the proposed mechanism — macrophage activation, T-cell priming, and NK-cell stimulation — operates through the pattern-recognition-receptor pathways that beta-glucan structures engage in the innate immune system.[2]
2. Eritadenine and Cholesterol-Metabolism Research
Eritadenine is unique to shiitake among commonly formulated edible mushrooms — it is absent in reishi, lion’s mane, and others. In research it inhibits S-adenosylhomocysteine hydrolase, a mechanism studied in relation to cholesterol metabolism; animal-model studies have reported reductions in total cholesterol and LDL markers at doses comparable to standardized-extract levels.[3] This compound is what distinguishes shiitake extract from other functional mushrooms in the cholesterol-and-heart wellness product category.
3. Cosmeceutical & Skin Research
In research, standardized shiitake extract has been studied for inhibition of elastase and collagenase — two enzymes involved in degrading skin’s structural proteins. This dual-enzyme activity is the basis for growing interest in shiitake extract for anti-aging serum and nutricosmetic formulations as a naturally derived, multi-target active.[4]
Extract vs. Powder vs. Whole Mushroom: A Practical Comparison
| Form | Polysaccharide Content | Cell Wall Disruption | Best For |
|---|---|---|---|
| Fresh Mushroom | ~0.5–1% (wet weight) | None | Culinary use only |
| Dried Powder | 2–5% (variable) | Minimal — chitin wall intact | Food fortification at low dose; not suitable for functional specifications |
| Standardized Extract | 20–50% polysaccharides by UV-Vis (beta-glucan-specific available) | Complete — bioactives accessible | Immune supplements, cosmeceuticals, functional beverages, nutraceuticals |
| Ratio Extract | 10:1, 20:1 (HPLC fingerprint) | Complete | Functional foods & beverages, cost-effective formulations |
| Water-Soluble Extract | 20–35% (water-soluble fraction) | Complete — hydrophilic extraction | Clear beverages, RTD formats, effervescent tablets where clarity is required |
A common procurement mismatch is requesting “shiitake mushroom powder” when the formulation actually requires standardized extract. For products carrying structure/function specifications, dried powder is not a suitable raw material — only standardized extract with UV-Vis-verified polysaccharide (and, where relevant, beta-glucan-specific) content gives a defined, defensible specification.
Formulation Applications
- Immune-support supplements: Capsules and tablets at 200–500 mg standardized extract per serving. Common pairings: reishi, turkey tail, vitamin C
- Heart & cholesterol wellness formulas: Eritadenine content places shiitake extract in the cholesterol-and-heart wellness category alongside plant sterols, red yeast rice, and CoQ10
- Functional beverages: Water-soluble or ratio extract for clear liquid formats. Dissolves cleanly without sedimentation; mild umami note manageable with natural flavor masking
- Cosmeceuticals (topical): Water-soluble fraction for anti-aging serum and eye-cream formats; compatible with aqueous emulsion systems
- Nutricosmetics (beauty-from-within): Oral format spanning both immune and skin research areas — a single-ingredient, multi-format active
Sourcing Criteria: What to Require from Any Supplier
| Criterion | What to Require |
|---|---|
| Polysaccharide / Beta-Glucan Content | by UV-Vis per batch. Valeherb supplies 20–50% polysaccharides; for immune applications, request beta-glucan-specific quantification, as total polysaccharide readings can include non-bioactive fractions |
| Ratio Extract Verification | For 10:1 / 20:1 material, request the HPLC fingerprint and concentration ratio; note these are characterised by fingerprint, not a polysaccharide percentage |
| Lentinan Integrity | Optical rotation or structural confirmation that the triple-helix conformation is preserved post-extraction. Not all suppliers test for this |
| Extraction Source | Fruiting body preferred for highest beta-glucan and eritadenine concentration. Mycelium-on-grain products contain substrate starch — request source documentation |
| Third-Party COA | Polysaccharide/beta-glucan by UV-Vis, heavy metals (USP <232>), pesticide residues, microbial limits (USP <2021>), moisture — per production batch |
| Certifications | Non-GMO, Kosher/Halal for relevant markets. FDA-registered facility required for US supplement supply chains |
Regulatory Guidance
- US (DSHEA): Any structure/function claim on the finished product is the marketer’s responsibility to substantiate and must carry the FDA disclaimer; immune-support and antioxidant claims are the more readily supported areas from the beta-glucan literature. Cholesterol and cardiovascular claims sit closer to disease territory and need careful wording (for example, “supports healthy cholesterol levels already within the normal range”). Disease treatment claims require drug (NDA) approval
- EU: Shiitake is classified as a food ingredient. Functional health claims require submission to the EU health claims register (EC 1924/2006). Beta-glucan from oats and barley carry authorized cholesterol claims, but shiitake beta-glucan claims require separate substantiation
- Japan: Lentinan holds approved drug status in Japan for intravenous use as an oncology adjunct. This is the regulatory status of the pharmaceutical, included only as background context — it is distinct from supplement applications and is not a claim for any supplement product
References
[1] Gaullier JM et al. (2011). Supplementation with a soluble β-glucan exported from shiitake medicinal mushroom, Lentinus edodes (Berk.) Singer mycelium: a crossover, placebo-controlled study in healthy elderly. International Journal of Medicinal Mushrooms, 13(4), 319–326. PMID: 22164761
[2] Wasser SP. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60(3), 258–274. doi:10.1007/s00253-002-1076-7
[3] Sugiyama K et al. (1995). Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats. Journal of Nutrition, 125(8), 2134–2144. doi:10.1093/jn/125.8.2134
[4] Kucuk SD et al. (2026). Cosmeceutical and dermatological potential of shiitake mushroom (Lentinula edodes) extract. Journal of Cosmetic Dermatology, 25(2), e70724. doi:10.1111/jocd.70724
[5] Bisen PS et al. (2010). Lentinus edodes: a macrofungus with pharmacological activities. Current Medicinal Chemistry, 17(22), 2419–2430. doi:10.2174/092986710791698495
